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Epimorphin–/– mice have increased
intestinal growth, decreased susceptibility
to dextran sodium sulfate colitis,
and impaired spermatogenesis
Yuan Wang,1 Lihua Wang,1 Hristo Iordanov,1 Elzbieta A. Swietlicki,1 Qun Zheng,1
Shujun Jiang,1 Yuzhu Tang,1 Marc S. Levin,1,2 and Deborah C. Rubin1,3
1Department

3Department

of Medicine and 2Speciality Care Service Line, St. Louis VA Medical Center, St. Louis, Missouri, USA.
of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, Missouri, USA.

Dynamic and reciprocal epithelial-mesenchymal interactions are critical for the normal morphogenesis and
maintenance of epithelia. Epimorphin has been identified as a unique molecule expressed by mesenchymal
cells and myofibroblasts and has putative morphogenetic effects in multiple epithelial tissues, including intestine, skin, mammary gland, lung, gallbladder, and liver. To define the in vivo role of epimorphin, we created
epimorphin-null mice by targeted inactivation of the epimorphin gene. Male epimorphin–/– mice are sterile
due to abnormal testicular development and impaired spermatogenesis. Intestinal growth is increased in
epimorphin–/– mice due to augmented crypt cell proliferation and crypt fission during the neonatal (suckling)
period, mediated at least in part by changes in bone morphogenetic protein (Bmp) and Wnt/β-catenin signaling pathways. Colonic mucosal injury and colitis induced by dextran sodium sulfate (DSS) are ameliorated
in epimorphin–/– mice, probably due to the increased proliferative capacity of the epimorphin–/– colon. These in
vivo findings support the notion that epimorphin is a key stromal regulator of epithelial cell proliferation
and growth in the intestine. In addition, our studies demonstrate a novel and critical role for epimorphin in
regulating testicular development and growth as well as spermatogenesis.
Introduction
Dynamic and reciprocal signaling between epithelium and mesenchyme is required for the growth and morphogenesis of epithelial
tissues (1–3). ECM molecules, mesenchymal cell surface molecules,
and soluble growth factors produced by mesenchyme regulate epithelial morphogenesis. Examples of mesenchymal factors include
hepatocyte and fibroblast growth factors as well as members of the
forkhead and bone morphogenetic protein (Bmp) molecule families, which regulate epithelial growth and promote morphogenesis
and differentiation (4–6).
Epimorphin is a unique mesenchymal molecule that has
morphogenetic effects in multiple epithelial tissues, including
intestine, pancreas, mammary gland, lung, gallbladder, and liver
(7–12), yet its precise in vivo functions remain unknown. We
have shown that epimorphin is expressed in the mesenchyme
of the developing fetal gut (13) and in intestinal myofibroblasts
(14, 15), which form a subepithelial network that is in intimate
contact with the crypt and villus epithelial cells. Epimorphin is
most abundantly expressed in the fetal gut mesenchyme during
villus morphogenesis, when mesenchymal cells invaginate into
the undifferentiated endoderm and form small finger-like villus
structures and proliferating cells become confined to the intervillus regions of the small and large bowels (the future crypts of
Nonstandard abbreviations used: BAC, bacterial artificial chromosome; BMP, bone
morphogenetic protein; DSS, dextran sodium sulfate; ISEMF, intestinal subepithelial
myofibroblasts; Neo, loxP-flanked neomycin.
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Lieberkühn in the small bowel and colonic crypts in the large
bowel) (16). Changes in the level of epimorphin expression by
transfection of sense or antisense epimorphin constructs into
myofibroblasts dramatically affects the morphology of cocultured epithelial cells (15). Inhibition of epimorphin expression
promotes the growth and spreading of cocultured epithelial cells,
and overexpression of epimorphin in myofibroblasts induces
the formation of round epithelial colonies that develop small
lumens. In addition, we showed that retinoic acid treatment of
myofibroblasts derived from neonatal ileum upregulates epimorphin expression (14). These studies suggest that epimorphin
might exert antiproliferative, promorphogenetic effects on adjacent epithelium. Our findings complement studies in skin, lung,
mammary gland, colon, gallbladder, and pancreas that indicate
that epimorphin is expressed in fibroblasts and myofibroblasts
surrounding the epithelium (9). In each tissue, epimorphin has
been postulated to function as a regulator of epithelial morphogenesis, promoting branching or the formation of ductular or
luminal structures in these epithelia (12).
Epimorphin is a member of the syntaxin family of membrane-bound, intracellular vesicle-docking proteins (identical to
rat syntaxin 2). These proteins are known as target membrane
SNAREs (t-SNAREs). Monomeric epimorphin has been detected
intracellularly as a component of the SNARE machinery that
targets vesicles to the plasma membrane (17, 18). As such, it has
been postulated to be involved in regulating the release of growth
and/or morphogenetic factors by mesenchymal/myofibroblast
cells (15). However, studies in the mammary gland have shown
that dimeric and tetrameric epimorphin molecules are found on
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Figure 1
Generation and characterization of epimorphin–/– mice. (A) Targeting
scheme to disrupt the epimorphin locus. Homologous recombination
between the targeting vector and the WT allele produced the targeted
allele in which 30 bp of the coding sequence in exon 1 and 1015 bp in
intron 1 of the epimorphin gene were replaced by the coding sequence
of enhanced GFP and a Neo cassette. The black bar represents the
location of the probe used to identify targeted ES cell clones. The
arrows denote the position of the initiator methionine of epimorphin
and GFP. (B) Southern blot hybridization of Hind III–digested genomic
DNA. A 10.4-kb band in the targeted allele and 8.7-kb band in the WT
allele were produced as expected. (C) Immunoblot analysis of protein
extracts from epimorphin WT (+/+), heterozygous (+/–), and null (–/–)
mice. Total protein from small intestine, colon, liver, kidney, and testis
(100 μg per tissue) was loaded onto the gel. Epimorphin was reduced
in the tissues of heterozygous mice and absent in null mice.

the extracellular surface of stromal cells (7, 10) and thus are presumed to transmit signals by interacting with putative epithelial
epimorphin receptors that have not yet been identified. Soluble
monomeric and dimeric epimorphin molecules were also detected
in dam’s milk (10), suggesting that epimorphin might also act as a
soluble factor in regulating epithelial morphogenesis.
Although previous data are consistent with a role for epimorphin in morphogenesis, the precise role of epimorphin in vivo is
unclear. To clarify the physiological role(s) of epimorphin, epimorphin–/– mice were created by targeted inactivation of the epimorphin
gene. The studies reported here present compelling evidence that
epimorphin is a key mesenchymal factor regulating the proliferation of the intestinal epithelium and is essential for normal spermatogenesis and morphogenesis of the testis.
Results
Generation of epimorphin–/– mice. To study the in vivo role of epimorphin, epimorphin–/– mice were generated by targeted homologous
recombination. The targeting construct was designed to replace
the initiator methionine and coding sequence of epimorphin exon
1 with that of GFP and a loxP-flanked neomycin (Neo) cassette
(Figure 1A). The generation of epimorphin heterozygous (+/–) and
null (–/–) mice was confirmed by Southern blot hybridization
analysis (Figure 1B). Immunoblot analyses confirmed the absence
1536
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of epimorphin in the small intestine, colon, kidney, liver, and testis
of epimorphin–/– mice and demonstrated decreased epimorphin in
epimorphin +/– mice (Figure 1C).
To determine whether the decrease in epimorphin (identical to
rat syntaxin 2) expression might affect expression of other syntaxins in the heterozygous and null mice, immunoblots using specific
anti–syntaxin 1 and anti–syntaxin 4 antibodies were performed,
with protein from intestine, colon, liver, kidney, lung, testis, and
brain (for syntaxin 1). Syntaxin 1 was expressed only in brain and
was not present in epithelial tissues, including small intestine,
colon, and lung from WT, heterozygous, or null mice. Syntaxin 4
was expressed in small intestine, colon, lung, kidney, and testis; syntaxin 4 protein levels were unchanged in epimorphin+/+, epimorphin+/–,
or epimorphin–/– mice (Supplemental Figure 1; supplemental material available online with this article; doi:10.1172/JCI25442DS1).
Male epimorphin–/– mice are infertile. Intercrosses of epimorphin+/–
mice produced the expected ratio of WT (n = 144), heterozygous
(n = 250), and homozygous mutant mice (n = 126). Male and
female epimorphin–/– mice were viable, grew normally to adulthood,
and appeared healthy without excess mortality for up to 1 year of
observation. Organogenesis was intact. Hair growth and patterning as well as skin quality and integrity appeared intact.
Breeding pairs that included male epimorphin–/– mice were unsuccessful at producing offspring whereas matings that included female epimorphin+/– or epimorphin–/– with male epimorphin+/+ or epimorphin+/– mice
were successful (Table 1). The results of these pairings indicate that
male epimorphin–/– mice are infertile. Compared with heterozygotes,
epimorphin–/– females gave birth to smaller litters (P < 0.05; Table 1).
However, the number of epimorphin+/–and epimorphin–/– pups followed
the expected Mendelian inheritance pattern. Epimorphin–/– and epimorphin+/– dams nursed their pups without apparent difficulty.
To evaluate infertility in the male epimorphin null mice, testicular development and morphology were analyzed. At 3 weeks
postpartum, the testes of epimorphin–/– mice weighed 20% less than
those of WT mice (Figure 2A). By 4 months, the testes of epimorphin–/– mice weighed less than 50% of WT mouse testes (Figure 2A).
Histological evaluation demonstrated profound germ cell degeneration in the testes of adult epimorphin–/– mice (Figure 2, C and D)
compared with WT (Figure 2B). Spermatogonia and spermatocytes
were present in seminiferous tubules, but spermatids were depleted and mature spermatozoa were not seen. Meiotic germ cells were

Table 1
Reproductive defects in epimorphin–/– mice
Genotype
Male (n)

Female (n)

Litter number

+/+ (1)
+/– (4)
+/– (20)
–/– (10)

–/– (3)
–/– (7)
+/– (30)
+/+ (10)
+/– (10)
–/– (10)

3
12
62
0
0
0

Litter size
(mean ± SEM)
6.3 ± 1.2
6.5 ± 0.8A
8.4 ± 0.2
0
0
0

Breeding pairs of various genotypes of mice, ranging from 8 to 16 weeks
old, were caged together for 10–16 weeks. Each male was housed with
1–4 females. Pregnant females were separated before delivery. The
number of pups in each litter was recorded within 24 hours after birth.
AP < 0.05 compared with male epimorphin+/– × female epimorphin+/–.
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Figure 2
Comparison of testicular weight and histology in WT and epimorphin–/–
mice. (A) Testes of 3-week-old and 4-month-old WT (n = 16 and 29,
respectively) and epimorphin–/– (KO) mice (n = 16 and 13, respectively)
were dissected and weighed. Data are expressed as mean ± SEM.
*P < 0.005; **P < 0.001. (B–G) Testes from 3-month-old mice of various
genotypes. (B) Representative H&E-stained cross section of testis from
a WT mouse, demonstrating normal spermatogenesis. (C) Representative cross section from an epimorphin–/– mouse. Note the absence of
spermatids in the seminiferous tubules and the detachment of meiotic
germ cells in clusters from the basal lamina of seminiferous tubules
(arrows). (D) Cross section from an epimorphin–/– mouse, demonstrating germ cells in the seminiferous tubule exhibiting the darkly stained
condensed nuclei that are characteristic of apoptotic cells (arrows). (E
and F) Sections from a WT testis (E) and an epimorphin–/– testis (F)
incubated with an anti–5-BrdU antibody to detect proliferating spermatogonia, as described in Methods. (G). Immunohistochemical analysis of epimorphin expression in normal testes. Sections were incubated
with an anti–syntaxin 2 antibody preabsorbed with testis protein isolated from epimorphin–/– mice and were stained as described in Methods.
Arrows indicate brown stain in Leydig cells.

detached in clusters from the basal lamina of seminiferous tubules
(Figure 2C). Increased numbers of apoptotic germ cells exhibiting
darkly stained condensed nuclei were found in many seminiferous
tubules (Figure 2D). Proliferation of spermatogonia appeared normal in epimorphin–/– mice, as indicated by immunohistochemical
detection of 5-BrdU incorporation in WT (Figure 2E) or epimorphin–/– mice (Figure 2F), but no mature sperm were produced in
epimorphin–/– mice. These findings indicate that the formation of
mature spermatozoa was compromised in epimorphin–/– mice.
Localization of epimorphin expression in the testis was evaluated
by immunohistochemical techniques. A polyclonal anti-epimorphin
(syntaxin 2) antibody purified by preabsorption with epimorphin

null mouse testis protein was utilized. In WT testes, epimorphin was
most abundantly expressed in Leydig cells (Figure 2G); much lighter
brown staining was also found in cells of the seminiferous tubules.
Staining was absent in epimorphin null testes.
Increased intestinal crypt cell proliferation, crypt depths, villus heights,
and crypt fission in neonatal, suckling mice. Previous data suggested
that epimorphin regulates cellular proliferation and crypt villus
morphogenesis in the gut epithelium (15, 16). Our initial phenotypic analysis of the epimorphin–/–mouse revealed that, in addition
to changes in testicular size, small bowel and colonic lengths were
increased in 4-month-old epimorphin–/– mice compared with WT
(Figure 3, A and B). In addition, liver weights were increased in
adult epimorphin–/–mice compared with WT littermates (Figure 3C).
No differences in other organ weights were noted in null versus
WT mice. These findings suggest that epimorphin deletion affects
the growth of intestine and liver in neonatal life, when accelerated
organ growth is required for normal development.
Therefore, histological and detailed morphometric analyses
were performed to elucidate the effects of epimorphin deletion
on the ontogeny and growth of the small intestine. Morphometric
analyses using 3- week-old and 4-month-old mice were performed
(Figures 4 and 5). Both villus lengths and crypt depths were signifi-

Figure 3
Comparison of small intestinal and colonic lengths and liver weights in adult (4 months old) WT and epimorphin–/– mice. (A) Small intestinal
lengths, (B) colonic lengths, and (C) liver weights were measured in 4-month-old WT (male, n = 16; female, n = 9) and epimorphin–/– (male, n = 13;
female, n = 16) mice as described in Methods. Data are expressed as means ± SEM. *P < 0.05; **P < 0.005; #P < 0.02.
The Journal of Clinical Investigation

http://www.jci.org

Volume 116

Number 6

June 2006

1537

Downloaded on August 5, 2013. The Journal of Clinical Investigation. More information at www.jci.org/articles/view/25442

research article

Figure 4
Quantitative morphometric analysis of the small intestines of 3-weekold WT and epimorphin–/– mice. (A) Villus heights, (B) crypt depths, (C)
crypt cell proliferation, i.e., 5-BrdU incorporation, and (D) crypt fission
in proximal jejunum from WT and epimorphin–/– mice were measured
as described in Methods. Data are expressed as mean ± SEM. WT,
n = 14; KO, n = 16. *P < 0.05; **P < 0.02.

cantly increased in the small intestine of 3-week-old epimorphin–/–
mice compared with WT littermates (Figure 4, A and B). Crypt cell
proliferation was also increased in epimorphin–/– mice (Figures 4C
and 5, A and B). Villus length, crypt depth, and crypt cell proliferation were also increased in epimorphin+/– mice compared with WT
mice (P < 0.001 for villus length; P < 0.02 for crypt depth; and P < 0.01
for crypt cell proliferation). In suckling mice, accelerated small
bowel growth occurs by crypt fission. The percentage of duplicated
small intestinal crypts was greater in 3-week-old epimorphin–/– mice
compared with WT mice (Figures 4D and 5, B and C). Crypt cell
apoptosis was unchanged (data not shown). Crypt and villus morphology appeared generally normal in the small intestine of epimorphin–/– mice. The small intestinal crypts of Lieberkühn are the site of

the putative epithelial stem cells and are the source of proliferating
precursor cells that give rise to the 4 major differentiated epithelial
cell types, including enterocytes, goblet cells, enteroendocrine cells,
and Paneth cells. All 4 epithelial cell types were present. However, in
3-month-old mice, and even as early as 3 weeks after birth, scattered
foci of abnormal villus branching were present in intestine of some
epimorphin–/– mice (Figure 5D). At 3 weeks of age, there were no
significant differences in the lengths of small intestine and colon
and in the weights of stomach, heart, lung, liver, spleen, and kidney
between epimorphin–/– and WT mice (data not shown).
Cell-specific epimorphin expression was studied in WT mouse
intestine by immunohistochemical analysis, using an anti–syntaxin 2 antibody that was preabsorbed with null mouse intestinal
protein. As previously described (13, 14), epimorphin is expressed
in pericryptal stromal cells (Figure 5E).
Epimorphin deletion alters Bmp and Wnt/β-catenin signaling pathways.
Elimination of epimorphin resulted in increased crypt cell proliferation and crypt fission in the neonatal gut, suggesting that
epimorphin might affect the stem cell niche and particularly the
production of proliferating daughter cells in the crypt. We therefore analyzed the expression of Bmps and other members of the
TGF-β superfamily in the epimorphin–/– and WT gut that are known
to affect the stem cell niche and the production of proliferating
daughter cells. Our previous data (15) indicated that Bmp 4 mRNA
expression was increased in epimorphin-transfected (overexpressing) gut myofibroblasts, suggesting that regulation of Bmps might
play a role in epimorphin’s effects on cocultured epithelial cells.
Bmp signaling has an antiproliferative effect in normal gut and
may act on the crypt epithelium via the Wnt pathway by inhibiting nuclear accumulation of β-catenin (19). To determine whether
enhanced proliferation in epimorphin–/– mice was associated with
decreased Bmp expression, quantitative RT-PCR was performed
using total RNA prepared from full thickness proximal jejunum of
null and WT mice. Bmp4 mRNA levels were decreased in null versus WT gut (22% decrease, P = 0.03; Table 2). Bmp2 mRNA levels

Figure 5
Crypt cell proliferation, crypt fission, villus morphology, and epimorphin
expression in small intestine of epimorphin–/– mice. (A and B) Representative histologic section depicting immunohistochemical detection
of 5-BrdU incorporation into crypt epithelial cells in proximal jejunum
of 3-week-old WT (A) and epimorphin–/– (B) mice. Note the increase in
5-BrdU–labeled cells in the null mice. (B and C) Crypt fission is detected in proximal jejunum of epimorphin–/– mice in 5-BrdU–immunostained
tissue (B, arrow) or in H&E-stained tissue (C, arrow). (D) Abnormal
villus morphology in 3-week-old epimorphin–/– intestine. (E) Epimorphin expression in stromal cells of jejunum. Epimorphin was detected
with an anti–epimorphin–syntaxin 2 antibody, which was preabsorbed
with purified intestinal protein from epimorphin–/– mouse jejunum,
as described in Methods. Arrows depict stromal myofibroblasts that
express epimorphin.
1538
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Table 2
Intestinal expression of Wnt and Bmp target genes and TGF-β
family genes in null versus WT mice
Gene

Fold change epimorphin–/–/WT

P value

Bmp4A

0.78
0.83
0.89
0.95
1.04
1.29
1.26
0.83

0.03
0.08
0.4
0.5
0.9
0.04
0.04
0.01

Bmp2A
TGF-β1A
TGF-β2A
TGF-β3A
c-MycB
Cyclin D1B
Smad7B

Quantitative real-time RT-PCR analyses were performed on proximal jejunal total RNA isolated as described in Methods. Results are expressed as
fold change in steady state mRNA levels: epimorphin–/–/WT. AWT, n = 10;
epimorphin–/–, n = 13; BWT, n = 18; epimorphin–/–, n = 20.

also tended to be decreased; (17% decrease, P = 0.08). In addition,
the expression of the Bmp downstream effector molecule Smad7
was significantly decreased (17% decrease, P = 0.01). Smad7 is also
a downstream target of TGF-β signaling; thus the expression of
TGF-β1, -β2, and -β3 was examined by quantitative RT-PCR and
was unchanged in null compared with WT mice. The effect on
Bmp signaling therefore appears to be specific in epimorphin–/–
mouse gut. To determine whether Wnt/β-catenin signaling is also
regulated, the expression of 2 downstream targets of Wnt, c-myc
and cyclin D1, was quantified; a 26% increase in cyclin D1 expression and a 29% increase in c-myc expression were found in null
compared with WT mouse gut (P = 0.04).
To further implicate increased β-catenin signaling as a mechanism for increased c-myc and cyclin D1 expression and increased
BrdU incorporation in epimorphin –/– intestine, nuclear fractions were prepared from the intestines of WT and null mice.
Immunoblot analysis was performed to assess nuclear and
cytoplasmic/membrane β-catenin levels. An increase in nuclear
β-catenin accumulation was noted in epimorphin–/– mice compared
with heterozygous and WT mice (Figure 6, A and B). To further
explore these results, immunohistochemical analysis was performed to detect β-catenin staining (Supplemental Figure 2). An
increase in intensity of staining in the nuclei of the crypt was noted
in the epimorphin–/– mice, consistent with the immunoblot results.
In addition, membrane staining was increased throughout the
crypt and along the villus.
To provide further evidence that Bmp signaling is regulated by
epimorphin and to determine the cell-specific expression of the
Bmps in relation to epimorphin, we examined Bmp expression
in cocultures of intestinal epithelial Caco-2 cells and intestinal
myofibroblasts that overexpress epimorphin or in which epimorphin expression is inhibited (as per ref. 15). The well-characterized
Mic216 ileal intestinal myofibroblast cell line (14, 15) was transfected with the full-length epimorphin cDNA in sense or antisense orientations, as previously described (15). Epimorphin was
overexpressed by 3- to 4-fold or was inhibited compared with vector control cells, as determined by immunoblot (data not shown).
These myofibroblasts were then cocultured with Caco-2 cells,
injected into the subcutaneous space of nude mice, and grown
for 6 weeks (Figure 7). In myofibroblast–Caco-2 cell grafts that
overexpress epimorphin, abundant Bmp expression was detected
The Journal of Clinical Investigation

by immunohistochemical techniques (Figure 7A) using an antibody specific for Bmp2 and Bmp4. Bmp expression was found in
both myofibroblasts and Caco-2 cells. In contrast, in cocultures
in which epimorphin expression was suppressed, Bmp expression
was inhibited in epithelial and myofibroblast cells (Figure 7B).
As we previously reported (15), Caco-2 cells, when cocultured
with myofibroblasts in which epimorphin expression is inhibited
(by stable transfection with epimorphin antisense cDNA), grow
rapidly over the surface of the myofibroblasts, producing large
Caco-2 cell colonies (Figure 8, A and B). In contrast, Caco-2 cells
cocultured with epimorphin-overexpressing myofibroblasts form
small, round, discrete colonies (15). To further test our hypothesis that the effect of epimorphin on intestinal growth is at least
in part mediated by Bmps, we treated Caco-2–antisense epimorphin myofibroblast cocultures with Bmp4 (100–200 ng/ml) and
observed whether or not addition of Bmps could inhibit Caco-2
cell colony growth on antisense myofibroblasts. As indicated in
Figure 8, C and D, addition of Bmp4 resulted in the formation
of round, discrete Caco-2 cell colonies (compared with control
panels in Figure 8, A and B), reversing the effects of epimorphin
inhibition. The appearance of these colonies reproduces what was
previously reported for Caco-2 cells cocultured on epimorphinoverexpressing myofibroblasts (ref. 15 and data not shown).
Protection from dextran sodium sulfate–induced colon epithelial injury in
epimorphin null mice. The gut trophic effects of epimorphin deletion
in neonatal mice indicated by an increase in crypt cell proliferation
suggested that downregulating epimorphin expression could also
enhance repair responses following intestinal injury. To test this
hypothesis, a well-characterized colitis model was used to study
mucosal injury and repair responses. Dextran sodium sulfate (DSS)
induces a chemical colitis characterized by mucosal ulceration, epithelial barrier disruption, and gland destruction followed by crypt cell
proliferation and mucosal repair (20, 21). The induction and severity
of DSS-induced colitis was compared in WT and epimorphin–/– mice.

Figure 6
β-catenin expression in epimorphin–/– and WT mouse intestine. Nuclear
protein isolation was performed as described in Methods. (A) Representative immunoblots of intestinal nuclear protein from WT, epimorphin–/–, and epimorphin+/– (HET) mice. Nuclear proteins (20 μg per lane)
were electrophoresed, and immunoblots were incubated with an anti–
β-catenin antibody. Blots were sequentially probed with an anti-lamin
B1 antibody to control for differences in loading. (B) Quantification of
nuclear β-catenin expression normalized to lamin B1 expression.
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Figure 7
Immunohistochemical analysis of Bmp expression in epimorphin-transfected myofibroblast–Caco-2 cell grafts in nude mice. Bmp expression was detected with an anti-Bmp2/Bmp4 antibody as described in
Methods. (A) Bmp expression in grafts containing epimorphin-overexpressing myofibroblasts. Thin arrows indicate stromal myofibroblasts
that exhibit increased Bmp expression. Thick arrow indicates Caco-2
epithelial cells that also show Bmp expression. (B) Bmp expression in
grafts containing myofibroblasts in which epimorphin is inhibited. There
is a marked decrease in Bmp expression in stromal myofibroblasts and
epithelial Caco-2 cells compared with A.

Cohorts of WT and epimorphin–/– mice were provided with either water
or water containing 5% (w/v) DSS for 7 days. Body weight change,
stool consistency, and the presence of fecal occult or gross blood were
recorded daily and used to calculate a clinical score (see Methods)
that reflected overall disease severity. After 7 days of DSS administration, body weight loss was less severe in epimorphin–/– mice than in WT
mice (–11.3% versus –17.6%, Table 3). Detection of fecal occult blood
was also delayed in epimorphin–/– mice and the morbidity, as measured
by the clinical scores, was less in the null mice (Table 3). The severity
of mucosal injury assessed microscopically correlated with the clinical score. Thus, histologic damage to the colonic mucosal glandular architecture was not as severe or extensive in epimorphin–/– mice
(Figures 9 and 10, A and B). Epimorphin–/– mice had a lower crypt
damage score in the proximal colon (Figure 9A) as determined by the
criteria in ref. 22. There were also significantly more areas of grade II
mucosal injury and fewer areas of grade IV (23, 24) mucosal injury
(Figures 9B and 10, A and B). These differences were more apparent in the proximal colon. After DSS treatment, crypt cell proliferation rates in the colonic mucosa of epimorphin–/– mice were further
increased compared with WT mice in areas adjacent to ulcerations
(as described in ref. 21) as well as distant from them (Figures 9C and
10, C and D). In proximal colon, 20.9% and 7.2% BrdU-stained crypt
epithelial cells were detected in epimorphin–/– and WT mice, respectively (Figures 9C and 10, C and D). In distal colon, 24.2% crypt epithelial cells were BrdU stained in epimorphin–/– mice while only 3.4%
crypt epithelial cells were BrdU-stained in WT mice. In addition,
epimorphin–/– mice demonstrated enhanced crypt cell hyperplasia in
nonulcerated areas following DSS injury. There were more epithelial
cells per crypt in the epimorphin–/– mice compared with WT mice in
both proximal and distal colons of DSS-treated mice (Figure 9D),
consistent with increased proliferation in epimorphin–/– mice. These
findings suggest that the reduced severity of colitis in epimorphin–/–
mice was probably due to mucosal protective effects resulting from
the increase in intestinal epithelial proliferation.
Discussion
Epimorphin–/– mice were generated to study the in vivo role of this
mesenchymal protein on gut morphogenesis. Epimorphin–/– mice
exhibited increased intestinal growth, with increased crypt cell pro1540
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liferation and crypt fission resulting in lengthening of the small
bowel. We hypothesized that the increased proliferative capacity of
the epimorphin–/– intestine might provide protection from mucosal
injury induced by DSS due to enhanced epithelial regeneration.
Null mice lost less weight, had delayed onset of gastrointestinal
bleeding detected by fecal occult blood testing, and sustained less
severe histologic injury, resulting in lower clinical activity scores.
Our studies suggest a unique role for stromal epimorphin in regulating epithelial cell proliferation in normal and regenerating gut.
In addition to the intestinal phenotype, epimorphin–/– mice had
increased liver weights, and male mice were infertile due to profound
abnormalities in spermatogenesis. Thus, although epimorphin is
expressed in many additional epithelial tissues (e.g., mammary gland,
kidney, and lung), the phenotypic changes were readily apparent only
in intestine, liver, and testis. This suggests that, compared with other
organs, epimorphin plays a more critical role in the regulation of gastrointestinal epithelial proliferation and testicular spermatogenesis.
The gastrointestinal tract and liver epithelium are both subject to
direct or indirect exposure to, and in some cases injury from, luminal
and ingested substances (e.g., food, toxins, and bacteria). In addition,
both the liver and the small intestine have significant regenerative
capability after loss of functional mass due to insults, such as ischemic injury. The generation of congenic epimorphin–/– mice may shed
more light on epimorphin’s role in other organs.
The small intestinal epithelium has a high basal rate of proliferation. Epithelial stem cells located near the base of the crypts of
Lieberkühn give rise to proliferating transit cells that differentiate into the 4 primary epithelial cell types as they migrate from
crypt to villus tip. Complete renewal of the mucosal absorptive
surface area occurs approximately every 3–5 days in the rodent and
human. Tight regulation of this process is critical for maintaining

Figure 8
Bmp4 alters growth and spreading of Caco-2 cells cocultured with epimorphin antisense-transfected myofibroblasts. (A and B) Caco-2 cells
were cocultured with epimorphin antisense-transfected myofibroblasts,
in which epimorphin expression had been inhibited, in vehicle control media. Large Caco-2 cell colonies are noted, spreading over the
myofibroblast surface (thin arrows). A few scattered smaller colonies
are also seen. Two different antisense transfected myofibroblast cell
clones are depicted in A and B. (C and D) Addition of 100 ng/ml (C) or
200 ng/ml (D) Bmp4 to epimorphin-antisense–transfected myofibroblast–Caco-2 cocultures. Thin arrows depict Caco-2 colonies. Note the
appearance of multiple small round colonies resulting from addition of
Bmp4. Only a few scattered larger Caco-2 cell colonies are seen, in C
only (short arrow). Magnification, ×100.
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Table 3
Reduced severity of DSS-induced colitis in epimorphin–/– mice

+/+ Vehicle
–/– Vehicle
+/+ DSS
–/– DSS

Body weight
loss (%)

Day FOB
first detected

Clinical
score

2.4 ± 1.3
2.1 ± 1.5
17.6 ± 1.7
11.3 ± 1.8A

N/A
N/A
2.9 ± 0.3
4.1 ± 0.2B

0.8 ± 0.3
1.0 ± 0.3
3.3 ± 0.2
2.6 ± 0.2A

Male WT (+/+) or epimorphin–/– mice received drinking water (vehicle)
with or without 5% DSS. Body weight change, stool consistency, and
detection of intestinal bleeding were recorded daily, and a clinical score
(scale 0–4) was calculated as described in Methods. Changes in body
weight after DSS administration for 7 days were expressed as percentage changes from initial weight. WT and epimorphin–/– mice receiving
water only, n = 6 and 6, respectively; WT and epimorphin–/– mice receiving 5% DSS in drinking water, n = 14 and 11, respectively. Data are
expressed as means ± SEM. AP < 0.02 and BP < 0.005 versus WT DSS.
FOB, fecal occult blood.

the intestinal mucosa and for preventing tumorigenesis. Our data
suggest that epimorphin normally functions as a negative regulator of epithelial proliferation; therefore it is not surprising that the
effects of epimorphin deletion were more easily detectable in the
highly proliferative intestine.
Intestinal subepithelial myofibroblasts (ISEMFs) are the source
of epimorphin in the mature small bowel (13, 15) and colon (25).
These cells form a pericryptal network that also extends into the vil-

lus core. ISEMFs are characterized by their location, expression of
smooth muscle α-actin, and absence of desmin (14, 26, 27). ISEMFs
are a source of paracrine growth factors supporting the proliferation and differentiation of epithelium (26). Functional heterogeneity has been demonstrated in this population (14). ISEMFs express
several Bmps, which act on the epithelium to inhibit crypt cell proliferation and crypt fission (15, 19) and have also been postulated
to produce Wnt signaling factors (6, 28). Epimorphin’s homology to the syntaxins (12, 29) suggests that it may play a novel role
in regulating the secretion of a subset of myofibroblast-derived
soluble factors that “condition” the crypt, such as the Bmps. Epimorphin deletion resulted in a significant decrease in Bmp and
Smad7 expression and an increase in expression of β-catenin and
of several downstream targets of the Wnt/β-catenin signaling pathway, including c-myc and cyclin D1. Our data provide further support for the findings of He et al. (19) showing that decreased Bmp
expression can affect intestinal stem cells, resulting in increased
crypt cell proliferation and crypt fission. Bmps appear to inhibit
nuclear accumulation of β-catenin by enhancing phosphatase and
tensin homolog (PTEN) activity, which represses Akt activity that
is required, with Wnts, to fully activate β-catenin in stem cells and
induce proliferation (19). A decrease in local Bmp production and/or
secretion induced by epimorphin deletion would be expected to
act on stem/progenitor cells to increase crypt cell proliferation
and crypt fission. Further support for this mechanism comes
from our prior studies showing that myofibroblasts overexpressing epimorphin induced the formation of small, compact colonies
of cocultured epithelial cells (15) and had increased Bmp4 expres-

Figure 9
Comparison of colonic epithelial injury and proliferation after DSS administration in WT and epimorphin–/– mice. Male WT and epimorphin–/– mice
were sacrificed after receiving drinking water with or without 5% DSS for 7 days. The colons were collected and processed for histological studies
as described in Methods. (A) The severity of epithelial injury was assessed by a grading system (22) described in Methods. Proximal colon, WT
and KO, n = 12 and 9, respectively; *P < 0.01; distal colon, WT and KO, n = 11 and 11, respectively. Data are expressed as means ± SEM. (B). The
percentages of fields involved with either grade I, II, III, or IV injury (23, 24) were quantified as described in Methods. WT, n = 9; KO, n = 9. Data
are expressed as means ± SEM. #P < 0.005, ##P < 0.05. (C) Colonic crypt cell proliferation was assessed by quantification of 5-BrdU incorporation.
Proximal colon, WT and KO, n = 12 and 7, respectively; distal colon, WT and KO, n = 6 and 4, respectively. Data are expressed as means ± SEM.
†P < 0.001. (D) Number of epithelial cells per colonic crypt. Proximal colon, WT and KO, n = 12 and 7, respectively; distal colon, WT and KO, n = 6
and 4, respectively. Data are expressed as means ± SEM. Increased crypt cell proliferation and crypt cell hyperplasia are noted in KO mice.
The Journal of Clinical Investigation
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Figure 10
Representative histologic sections demonstrating more severe mucosal injury in DSS-treated WT mouse colon and enhanced crypt cell
proliferation in DSS-treated epimorphin–/– mouse colon. (A and B)
Inflammatory cell infiltration and epithelial erosions were evident in
the colonic mucosa after 7 days of DSS administration. However, as
shown in representative H&E-stained histologic sections, ulcerative
lesions were more common in WT mice (A) and less severe injury (B)
was more frequent in epimorphin–/– mice. (C and D) Crypt cell proliferation in colonic mucosa adjacent to ulcerative lesions in DSS-treated
WT (C) and epimorphin–/– mice (D).

sion. Conversely, myofibroblasts in which epimorphin expression
was inhibited stimulated spreading and proliferation of cocultured
epithelium (15). In the present study, we have shown that addition
of Bmp4 reversed this effect (Figure 8). The suppressive effect of
Bmp signaling on intestinal crypt formation and polyp growth has
also been demonstrated in transgenic mice that overexpress noggin, a Bmp inhibitor, in the gut; these mice formed numerous ectopic crypt units throughout the gut (5). Our data suggest that Bmp
expression is decreased in both myofibroblast and epithelial cells
(Figure 7). We have previously shown that epimorphin is expressed
in myofibroblasts but not in Caco-2 or other epithelial cells (15,
16); thus the effects of epimorphin deletion on Bmp expression in
epithelial cells are not likely to be direct but rather related to myofibroblast-epithelial interactions mediated by epimorphin.
Increased crypt fission in the intestine of juvenile epimorphin–/–
mice indicates that epimorphin regulates not only epithelial proliferation but also crypt duplication in the intestine. Crypt fission
is characterized by the presence of a bisecting fissure at the base of
the parental crypt and the longitudinal ascendance of the fissure,
leading to the production of 2 daughter crypts. Crypt duplication
by fission occurs with increased frequency during a brief period
of postnatal life, from approximately 5 to 21 days after birth (30).
Bmps are also involved in the regulation of de novo crypt formation in the intestine (5). Thus, the increased crypt fission seen in
epimorphin null mice may also be mediated via effects on Bmp
signaling. Noggin-expressing transgenic mice, which exhibit complete inhibition of Bmp signaling, form polyps in the small bowel
(5); we observed abnormal villus morphology with branching villi
in epimorphin–/– mice (Figure 4D).
Overexpression of a soluble form of epimorphin in mammary gland (using the whey acidic protein promoter to over1542
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express full-length epimorphin fused to the NH2-terminal
signal sequence of IL-2) promotes tumorigenesis in aged mice
(31). The fact that this phenotype results from overexpression
of epimorphin (which has been shown to promote mammary
morphogenesis but does not directly stimulate proliferation; ref.
7) and thus is opposite the observed phenotype in the epimorphin–/– mouse intestine suggests disparate roles for epimorphin
in different tissues and possibly unique effects of the soluble
form of epimorphin.
Epimorphin–/– mice were partially protected from colitis induced
by DSS. DSS colitis is thought to result from disruption of the
normal epithelial barrier, since changes in permeability occur
before the onset of frank inflammation (20, 32). This concept is
also supported by studies in intestinal trefoil factor null mice.
Absence of this protein, which is important in epithelial repair,
results in markedly worse colitis compared with WT mice (20,
33). Also, transgenic mice in which a dominant-negative TGF-β is
overexpressed in intestine (34) have worsened colitis and delayed
healing. In our mice, protection occurred early in the course of
the colitis (e.g., fecal occult blood appearance was delayed from
an average of 2.9 days following the start of DSS treatment in WT
mice to 4 days after the beginning of treatment in null mice), suggesting that enhanced crypt cell proliferation allowed for rapid
restoration of the mucosal surface barrier, increasing resistance to
ulceration and subsequent inflammatory response.
A remarkable increase in colonic crypt cell proliferation was seen
in the DSS-treated epimorphin–/– colon compared with the WT
colon. Previous studies in the DSS colitis model showed that intact
colonic mucosa adjacent to ulcerations exhibited enhanced crypt
cell proliferation compared with crypts in uninvolved mucosa
(21). We found that the epimorphin–/– DSS colon showed a marked
augmentation of crypt cell proliferation in mucosa adjacent to the
ulcerations as well as in the intact mucosa in other areas of the
DSS-treated colon compared with WT DSS-treated colon. Thus, in
DSS-induced colitis, deletion of epimorphin may further enhance
proliferation, as we postulated to occur in the normal gut.
Alternatively, in the colitis model, other mediators may be responsible for the protective effects resulting from epimorphin deficiency. Intestinal myofibroblasts can react to inflammatory signals by
expressing cytokines (26, 35–37). For example, exposure to bacteria
activates these cells (38). Myofibroblasts express toll-like receptors
1–9, NOD1, NOD2, and Myd88, and lipopolysaccharide upregulates a subset of toll-like receptors in these cells (37) that in turn
leads to release of mediators of inflammation. In DSS colitis, loss
of barrier function is thought to permit entrance of bacteria into
the subepithelial space, thereby eliciting an inflammatory response
(20). Loss of epimorphin did not appear to affect the myofibroblast
response by decreasing secretion of cytokines or other proinflammatory molecules and thus reducing the inflammatory response
since cytokine expression was unchanged in epimorphin–/– mice.
Finally, it is possible, albeit less likely, that macrophage function is
affected in epimorphin–/– mice. Syntaxin 2, the rat homolog of epimorphin, was shown to be expressed in the macrophage although
the antibody used in those experiments cross-reacts with syntaxin
4 and 6, which are also expressed in macrophages (39). The latter
syntaxins, but not syntaxin 2, have been linked to the regulation
of secretion of cytokines such as TNF-α (40, 41), and syntaxin 4 is
regulated by LPS (40). Furthermore, our previous studies and those
of other investigators show that in the adult gut, epimorphin is
expressed in myofibroblasts but not macrophages (13, 25). Thus,
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it is likely that elimination of epimorphin expression in intestinal
myofibroblasts and not macrophages is the most plausible explanation for the protective effects seen in the DSS colitis model. Further
studies will be required to determine the precise mechanism underlying the protection of epimorphin null mice from colitis.
The proliferative phenotype demonstrated in the intestinal epithelium in normal neonatal and in DSS-treated mice is consistent
with our previous, albeit indirect in vivo studies of epimorphin
function in the gut. For example, epimorphin expression was
reduced in the remnant gut following partial small bowel resection
(13). In this model of intestinal adaptation, crypt cell proliferation
is markedly upregulated. The decrease in epimorphin expression
coincided with the onset of enhanced crypt cell proliferation, suggesting that diminished epimorphin expression occurs in concert
with increased epithelial proliferation.
The loss of epimorphin also adversely affected germ cell development, as testicular size and spermatogenesis were markedly
diminished in the epimorphin null mouse. Disrupted germ cell
differentiation and augmented apoptosis were associated with
marked depletion of spermatids in the testes of epimorphin–/–
mice. Seminiferous tubules contained proliferating spermatogonia and spermatocytes, but spermatids and mature spermatozoa were not observed. Sertoli and Leydig cells were present.
Our immunohistochemical studies suggest that epimorphin is
expressed in Leydig cells (Figure 2), with lower expression in other
cells of the seminiferous tubules. Syntaxin 2 is associated with
spermatic membranes and is expressed in the acrosomal region
of the sperm (42, 43). Thus, a role for syntaxin 2 in the acrosomal
reaction had been suggested (42). However, since mature sperm
were not produced in epimorphin–/– testes, our results indicate that
epimorphin plays an earlier role, possibly in the development of
spermatids from spermatocytes. Leydig cells were histologically
normal in epimorphin null testes, but their function has not been
explored in these studies. It is possible that epimorphin deficiency
affects the ability of fibroblast-like progenitors of Leydig cells to
secrete growth factors, since large quantities of these are produced
by these cells from postnatal day 14 to 21 (44). Testicular development was also impaired prior to the time when Leydig cells normally produce and secrete large amounts of testosterone.
Reproductive-related functions were also examined in female
epimorphin null mice. The number of pups per litter was reduced
in matings of female epimorphin–/– mice with male epimorphin+/–
mice compared with epimorphin+/– female mice with male epimorphin+/– mice. Since epimorphin is expressed in the inner cell mass
and in trophoectoderm, it has been postulated to play a role in trophoblast outgrowth (45). Nevertheless, the ratio of heterozygous
to null mice was as expected. Thus, the reduction in litter size was
not due to preferential loss of epimorphin null offspring. These
observations suggest that a maternal factor might be responsible
for the reduction in litter size. Epimorphin has a well-characterized role in mammary gland ductule formation and tubulogenesis
(7, 10, 12), yet female epimorphin null mice were able to nurse
their pups without difficulty. Thus, mammary gland development
was grossly unaffected by epimorphin deficiency. Other maternal
factors such as mild placental insufficiency cannot be ruled out at
this time and will be further explored in future studies.
In conclusion, the phenotype of epimorphin–/– mice suggests
several novel in vivo functions for epimorphin. These studies
provide evidence that epimorphin is a key regulator of epithelial growth in the intestine and is required for normal testicular
The Journal of Clinical Investigation

morphogenesis and spermatogenesis. The observation that epimorphin deficiency resulted in increased crypt cell proliferation
and partial protection from DSS colitis suggests the possibility
that modulation of epimorphin expression could be used therapeutically to increase mucosal regeneration following injury to
the gut resulting from inflammatory bowel disease or ischemia
or following intestinal resection.
Methods
Generation of epimorphin–/– mice. A genomic bacterial artificial chromosome
(BAC) clone was obtained by screening a 129/SvJ BAC mouse ES cell library
with a 350 bp mouse epimorphin cDNA clone (Incyte). Fragments from
EcoR I digestion of the BAC clone were subcloned into pBluescript SK(–)
(Stratagene). Clones containing the epimorphin gene were identified by
colony hybridization and mapped by partial sequencing. To create the
5′ arm, a 4.7 kb fragment upstream of the epimorphin initiator ATG was
obtained by Bgl I digestion of the BAC clone. To create a GFP knockin
construct, pEGFP-N1 (BD Biosciences — Clontech) was used as a template
for the amplification of the coding sequence and polyadenylation signal of
GFP. A GFP 5′ primer was designed for the introduction of a Bgl I restriction site and the replacement of the epimorphin initiator ATG with that
of GFP (5′-CGGGCCCGGCCCTGCTGGCCGGTGGGGATGGTGAGCAAGGGCGAG-3′). A GFP 3′ primer was designed to introduce an Apa
I site at the 3′ end of the PCR products (5′-GGTTATCCGGCTTTAGCCGTCCCGGGGAATATTTAGTTTTCTTAT-3′). Ligation of the 4.7 kb epimorphin 5′ arm fragment and the Bgl I digested GFP PCR product created
an “Epi 5′ arm–GFP” fragment. This fragment was then digested with Apa
I and subcloned into the Apa I site of phosphorylated Neo (p-Neo) plasmid
1339 (GenBank accession number AF335420, Embryonic Stem Cell Core,
Washington University School of Medicine). The 3.2 kb epimorphin 3′ arm
was obtained by Kpn I digestion of the BAC clone and subsequently subcloned into Kpn I site of p-Neo plasmid 1339 containing the Epi 5′ armGFP fragment. The construct was sequenced (Protein and Nucleic Acid
Chemistry Laboratory, Washington University School of Medicine) at all
ligation junctions to ensure base sequence fidelity. The vector was then
linearized with BspH I and electroporated into the RW-4 subclone of ES
cells derived from 129/SvJ mice (Embryonic Stem Cell Core, Washington
University School of Medicine). Genomic DNA was isolated from G418resistant ES cell colonies. Southern hybridization assays were performed
on Hind III digested DNA using a 32P-labeled 150 nucleotide probe corresponding to sequence upstream of the 5′ arm (Figure 1). In 2 out of 120
clones, an expected 10.4 kb band was detected in addition to the 8.7 kb
WT band, indicating the replacement of one of the epimorphin alleles by
homologous recombination. Complete integration of the targeting construct was confirmed by additional Southern hybridization analysis.
The positive ES clones were individually injected into C57BL/6 blastocysts and implanted into pseudopregnant females. Chimeric founders
derived from both lines produced offspring containing the targeted allele
when crossed with C57BL/6J females. Intercrosses of the heterozygotes
produced viable homozygous epimorphin–/– mice at the expected Mendelian
frequency in both sexes. The 2 lines of mice were maintained separately on
a C57BL/6J 129/SvJ background. Epimorphin–/– mice from both lines were
phenotypically identical. All experiments were performed within the same
generation, using WT littermates of the epimorphin–/– mice for controls.
All mice were housed in the Washington University School of Medicine
barrier facility in a 12-hour light-dark cycle with free access to food and
water. The mice were fed a standard rodent chow diet (PicoLab 20; Purina).
Age-matched null mice and their WT littermates were used in all experiments
as described in Results. All animal experimentation was approved by the Animal Studies Committee of Washington University School of Medicine.
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To evaluate the phenotype of the epimorphin–/– mice, mice were weighed
and sacrificed at various ages as described. Small intestines and colons
were harvested, and their lengths were measured by suspension with a
fixed weight (2.6 g). Small intestines were then divided into 4 segments.
The proximal 5 cm of the small intestine was collected as duodenum. The
remainder was divided into 3 equal parts representing proximal jejunum,
distal jejunum, and ileum. Colons were divided into 2 equal parts called
proximal colon and distal colon. Testis, liver, spleen, heart, lung, kidney,
and stomach were harvested and weighed. Skin was collected for histological analyses. Tissues were frozen in Tissue-Tek O.C.T. Compound (Sakura
Finetek) for frozen histologic sections or in liquid nitrogen for total RNA
and protein isolation or placed in 10% formalin (Sigma-Aldrich) for histochemical and immunohistochemical analyses.
Microscopic analysis of testicular morphology. Histologic sections were prepared
from formalin-fixed, paraffin-embedded, or frozen testes by the Morphology Core of the Washington University Digestive Diseases Research Core
Center. Routine H&E staining was performed on paraffin sections. Proliferating cells (spermatogonia) were identified by immunohistochemical detection of the incorporation of 5-bromodeoxyuridine into DNA (see Analysis of
intestinal morphometrics, proliferation, and apoptosis, below).
Immunohistochemical analyses. Epimorphin expression in WT testis and
intestine was analyzed using a polyclonal rabbit anti–syntaxin 2 antibody
(1:500 dilution; Synaptic Systems) that was purified by preabsorption with
purified protein from epimorphin null mouse testis or intestine (1 μg of antibody incubated with 50 μg protein). Sections were pretreated with Nuclear
DECLOAKER reagent (Biocare). Antigen-antibody complexes were detected with biotinylated goat anti-rabbit IgG and streptavidin–horseradish peroxidase with tyramide amplification, developed in diaminobenzidine.
Immunohistochemical analyses of BMP expression were performed using
a polyclonal goat anti-recombinant human BMP2/4 antibody (1:300 dilution; R&D Systems) that cross-reacts with mouse. Antigen retrieval was
performed with citraconic anhydride; antigen-antibody complexes were
detected with a biotinylated donkey anti-goat IgG, detected with streptavidin–horseradish peroxidase and diaminobenzidine. Nuclear β-catenin
immunostaining was performed using a polyclonal rabbit anti–β-catenin
antibody (Sigma-Aldrich, 1:30). Sections were pretreated with Nuclear
DECLOAKER reagent (Biocare).
Induction and assessment of DSS-induced colitis. The well-established model
of DSS-induced colitis was utilized (20, 23, 34). Male WT and epimorphin–/– mice of 12 to 18 weeks of age were divided into 2 groups receiving either water alone (control) or 5% (w/v–1) DSS (40,000–50,000 MW;
USB Corp.) in water ad libitum for 7 days. Mice were checked daily for
development of colitis by monitoring body weight, fecal occult blood
(One-Step; Henry Schein Inc.) or gross rectal bleeding, and stool consistency. The overall disease severity was assessed by a clinical scoring
system with a scale of 0–4, as per ref. 46. In brief, scoring was as follows:
0, no weight loss, no occult blood in the stools, and normal stool consistency; 1, weight loss of 1–5%, no occult blood, and normal stool consistency; 2, 5–10% weight loss, positive for fecal occult blood, and loose
stools; 3, 10–20% weight loss, positive for fecal occult blood, and loose
stools; and 4, greater than 20% weight loss, gross (visible) rectal bleeding,
and diarrhea (loose stools with perianal soiling).
Animals were sacrificed by inhalational isoflurane (Baxter) overdose on
day 8. The colon was removed from its mesentery to the pelvic brim and
equally divided into proximal and distal segments before it was opened
longitudinally. The tissues were then fixed in 4% formaldehyde (Fisher
Scientific International) overnight and transferred to 70% ethanol. After
embedding in paraffin, longitudinal sections of the entire colon were prepared for histological studies. Mucosal injury was assessed under high
power (×200). Each field encompassed a circular area of 0.07 mm2. The
1544
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method of crypt scoring by Murthy et al. (22) was used, with the entire
colon assessed. In brief, scoring was a follows: 0, normal morphology; 1,
loss of lower third of the crypt; 2, loss of lower two-thirds of the crypt; 3,
loss of entire crypt but with remaining surface epithelium; and 4, loss of
entire glands and epithelium. Each field was assigned a grade of 0 to 4.
The changes were quantitated according to the percentage involvement
of the disease process: 1, 1–25%; 2, 26–50%; 3, 51–75%; and 4, 76–100% of
area examined. Each field was scored with a grade and percentage area of
involvement, and the product of the two was the crypt score for that field.
The scores from all fields in a segment of colon were summed, which
yielded a crypt score for that segment of the colon. A modified grading
scale of Egger et al. (24) and Okayasu et al. (23) was also used to assess the
microscopic mucosal injury in each field. The entire colon was assessed.
In brief, scores were determined as follows: 0, normal morphology; 1,
focal inflammatory cell infiltrate around the crypt base; 2, diffuse infiltration of inflammatory cells around crypts or erosion/destruction of
lower one-third of the gland; 3, erosion/destruction of lower two-thirds
or loss of all glands but with remaining surface epithelium; and 4, loss
of the entire glands and epithelium. Each field was assigned a grade of
0 to 4. The total number of fields demonstrating each injury grade was
quantified and expressed as a percentage of the total number of fields in
the longitudinal section of the colon for each mouse (no. of fields graded
0, 1, 2, 3, or 4/total fields examined).
Analysis of intestinal morphometrics, proliferation, and apoptosis. Histological sections were prepared and stained by the Morphology Core of the
Washington University Digestive Diseases Research Core Center. Routine H&E staining was performed on paraffin-embedded tissues for morphometric analyses as previously described (47, 48). Villus heights, crypt
depths, and crypt cell numbers were measured in all intestinal segments
in at least 10 well-oriented, full-length crypt-villus units. Quantitative
analyses were performed by AxioVision analysis of digitally acquired
images (version 2; Zeiss). Quantification of crypt fission was expressed
as the number of crypts undergoing fission per 100 crypts counted. A
crypt undergoing fission was defined as a bifurcating crypt with a bisecting fissure as illustrated in Figure 4, B and C, and per ref. 19. Crypt cell
proliferation was measured by quantifying 5-BrdU incorporation into
DNA, as previously described (48). Mice were injected intraperitoneally
with a solution of 5-bromodeoxyuridine (8 g/l) and 5-fluorodeoxyuridine (0.8 g/l), total dose 120 mg/kg, and were sacrificed 90 minutes after
injection. 5-BrdU was detected with a monoclonal anti-BrdU antibody
(Zymed Laboratories Inc.) and streptavidin-biotin amplification. Crypt
cell proliferation was expressed as the percentage of 5-BrdU–labeled cells
per 100 crypt cells. For colitis experiments, crypt cell proliferation was
assessed by quantifying 5-BrdU–labeled cells in all full-length crypts in
the longitudinal sections of colons. At least 20 full-length crypts per
sample were counted. Crypt cell proliferation indices were also quantified separately in areas adjacent to ulcerations and were compared with
each other in WT and epimorphin–/– mice. Quantification of apoptotic
cells was performed by morphologic assessment of tissues stained with
H&E, as previously described (48). The number of apoptotic cells per
crypt and per 1000 crypt cells was measured.
Immunoblot analyses. Protein extracts were prepared from small intestine, colon, kidney, liver, lung, brain, and testis, and 100 μg aliquots were
electrophoresed on 10% SDS-polyacrylamide gels and transferred onto
PVDF-plus membranes. Nuclear and cytoplasmic/membrane protein
preparations were performed as follows: intestines were homogenized in
Tris buffer containing 20 mM Tris-HCl, 2 mM EDTA, 10 mM EGTA, and
0.25 M sucrose and proteinase inhibitors and centrifuged at 100 g for 10
minutes. The pellet was discarded and the remaining supernatant centrifuged at 400 g. The pellet was discarded again, and the supernatant was
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recentrifuged at 1,500 g. Supernatant was saved for cytosolic/membrane
protein isolation. Nuclear protein was extracted from the pellet using
homogenization buffer plus Triton X-100 (0.2%), which was mixed vigorously and centrifuged at 4°C at 15,000 g for 1 hour. Nuclear proteins
were contained in the supernatant. Immunoblots were incubated with
a rabbit polyclonal anti-epimorphin/syntaxin 2 antibody (1:2000; gift
from B. Quinones, University of California Berkeley, Berkeley, California,
USA, and Mark K. Bennett, Chiron Corp., Emeryville, California, USA;
ref. 18), rabbit polyclonal anti–syntaxin 4 (1:1000; Synaptic Systems),
mouse monoclonal anti–syntaxin 1 (1:1000; Synaptic Systems), rabbit
polyclonal anti–β-catenin antibody (1:1000; Cell Signaling Technology),
or mouse monoclonal anti-actin antibody (1:1000; Chemicon International) to control for differences in total protein loading or mouse monoclonal anti-lamin B1 antibody (1 μg/ml; Zymed Laboratories Inc.) to control for differences in nuclear protein loading, followed by a horseradish
peroxidase–conjugated anti-IgG antibody (1;1000–1:10,000; Amersham
Biosciences), and developed with chemiluminescent peroxidase substrate
(ECL Western Blotting Kit; Amersham Biosciences). Relative abundance
of β-catenin and lamin B1 proteins were quantified by NIH Image 1.6
analysis of digitized images of the specific bands (http://rsb.info.nih.
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forward 5′-CATCCCAGGCCGACTAAATG-3′ and reverse 5′-TTTCAGAGCATTGGCCATAGAA-3′; TNF-α, forward 5′-TACCTTGTCTACTCCCAGGTTCTCT-3′ and reverse 5′-GTGTGGGTGAGGAGCACGTA-3′; IL-6,
forward 5′-CTTCCTACCCCAATTTCCAATG-3′ and reverse 5′-ATTGGATGGTCTTGGTCCTTAGC-3′.
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